Physician

Rachael E Harmon, M.D.

According to 2025 Medicare claims, Rachael Harmon, M.D. (NPI: 1760708614) practices radiation oncology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is SOUTHERN CANCER CENTER, PC (NPI: 1578629556; TIN: 208097639) and primary practice location at 36535-2229.

Harmon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 224 traditional Medicare patients, billed 6,534 HCPCS/CPT codes, and received $977,568 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 275 prescription claims across 130 beneficiaries totaling $6,046 in drug costs, led by Ssd (Silver Sulfadiazine). Open Payments data shows 65 records totaling $1,241. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $26,667 to $977,568. Similarly, Part D prescription costs have risen steadily, from $615 to $6,046. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$489K$978K2015 Medicare payment: $26,667 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $59,503 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $36,239 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $57,554 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $93,119 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $93,635 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $74,649 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $283,976 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $793,155 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $977,568 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201522386$26,667
201658824$59,503
201765524$36,239
2018110832$57,554
20191451,367$93,119
20201271,451$93,635
20211241,209$74,649
20221402,268$283,976
20231314,955$793,155
20242246,534$977,568

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.6K$7.2K2015 Drug cost: $615 (USD; Tot_Drug_Cst)2016 Drug cost: $1,343 (USD; Tot_Drug_Cst)2017 Drug cost: $2,860 (USD; Tot_Drug_Cst)2018 Drug cost: $904 (USD; Tot_Drug_Cst)2019 Drug cost: $2,353 (USD; Tot_Drug_Cst)2020 Drug cost: $4,290 (USD; Tot_Drug_Cst)2021 Drug cost: $5,051 (USD; Tot_Drug_Cst)2022 Drug cost: $2,724 (USD; Tot_Drug_Cst)2023 Drug cost: $7,168 (USD; Tot_Drug_Cst)2024 Drug cost: $6,046 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R27$615
20164276$1,343
20174273$2,860
20183240$904
20196295$2,353
202056145$4,290
202180213$5,051
202255118$2,724
2023102283$7,168
2024130275$6,046

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more118118$156
77263Complex radiation therapy planning127136$118
77334Design and construction of complex radiation treatment device115405$89
77336Continuing radiation therapy consultation per week109254$59
77300Calculation of radiation therapy dose123515$47

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
SsdSilver Sulfadiazine401,147$1,323
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28240$560
Tamsulosin HclTamsulosin Hcl392,280$345
Triamcinolone AcetonideTriamcinolone Acetonide28868$299
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12140$257

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.65$1,241Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rachael E. Harmon, M.D.?

Tedicare shows public-source Medicare data for Rachael E. Harmon, M.D. (NPI 1760708614), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachael E. Harmon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rachael E. Harmon, M.D.?

Rachael E. Harmon, M.D. is linked to SOUTHERN CANCER CENTER, PC (billing NPI 1578629556) in the available physician profile data.

Does Rachael E. Harmon, M.D. have Open Payments data?

Rachael E. Harmon, M.D. has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.